Loading...
XJPX
4886
Market cap400mUSD
Jul 10, Last price  
2,259.00JPY
1D
-1.27%
1Q
-17.37%
IPO
53.78%
Name

ASKA Pharmaceutical Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:4886 chart
P/E
11.82
P/S
0.90
EPS
191.05
Div Yield, %
2.27%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
5.21%
Revenues
71.13b
+10.90%
30,301,391,00030,170,000,00030,422,000,00035,784,000,00045,849,000,00040,637,000,00040,963,000,00039,501,000,00042,907,000,00043,215,000,00048,527,000,00048,944,000,00046,705,000,00052,542,000,00055,181,000,00056,607,000,00060,461,000,00062,843,000,00064,139,000,00071,127,000,000
Net income
5.43b
+6.35%
969,658,0003,513,000,000600,000,00093,000,000-790,000,0007,000,0001,114,000,000495,000,0001,193,000,000701,000,0002,944,000,0002,388,000,0001,744,000,000649,000,0002,713,000,0004,290,000,0004,238,000,0007,545,000,0005,101,000,0005,425,000,000
CFO
6.30b
+153.64%
1,361,826,0006,014,000,000-215,000,0002,667,000,0003,558,000,000-2,514,000,0003,869,000,0002,616,000,0005,709,000,000-1,349,000,00012,063,000,00076,000,0002,504,000,000-492,000,0006,541,000,0002,842,000,0003,351,000,0001,486,000,0002,485,000,0006,303,000,000
Dividend
Sep 29, 202632 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
URL
https://www.aska-pharma-hd.co.jp/
IPO date
Apr 01, 2021
Employees
747
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT